Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Kubota Pharma, First Half Net Income Loss Narrows, Apr-Jun Net Income Loss Narrows
4596 Kubota Pharmaceutical Holdings Co., Ltd. 【IFRS】
Earnings ReportKubota Pharmaceutical Holdings Co., Ltd. <4596> [TSE Growth] announced its financial results (based on IFRS) after the market closed on August 14th (15:30). The consolidated net loss for the cumulative second quarter of the fiscal year ending December 2025 (January to June) was a reduced loss of 450 million yen (compared to a loss of 669 million yen in the same period last year).
In the most recent three-month period, from April to June (2Q), the consolidated net loss improved to a deficit of 191 million yen (compared to a loss of 326 million yen in the same period last year). The operating profit/loss margin improved from -6760.0% in the same period last year to -3183.3%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2023 | 17 | -747 | -745 | -745 | -13.5 | ー | Aug 10, 2023 | IFRS |
| Jan - Jun, 2024 | 10 | -675 | -669 | -669 | -11.9 | ー | Aug 14, 2024 | IFRS |
| Jan - Jun, 2025 | 13 | -450 | -450 | -450 | -7.7 | ー | Aug 14, 2025 | IFRS |
| YoY | +30.0% | +33.3% | +32.7% | +32.7% | +35.2% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | IFRS |
| Jan - Jun, 2025 Results | 13 | -450 | -450 | -450 | -7.7 | 0 | Aug 14, 2025 | IFRS |
| Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 17 | -614 | -664 | -664 | -11.8 | 0 | Feb 14, 2025 | IFRS |
| Jul - Dec, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | IFRS |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Dec, 2023 | 40 | -1,504 | -1,490 | -1,490 | -26.8 | 0 | Feb 14, 2024 | IFRS |
| Dec, 2024 | 27 | -1,289 | -1,333 | -1,333 | -23.7 | 0 | Feb 14, 2025 | IFRS |
| Dec, 2025 Guidance | ー | ー | ー | ー | - | 0 | Feb 14, 2025 | IFRS |
| YoY | - | - | - | - | - |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Jun, 2024 | 5 | -338 | -326 | -326 | -5.8 | -6,760.0 | Aug 14, 2024 | IFRS |
| Jul - Sep, 2024 | 7 | -280 | -331 | -331 | -5.9 | -4,000.0 | Nov 14, 2024 | IFRS |
| Oct - Dec, 2024 | 10 | -334 | -333 | -333 | -5.9 | -3,340.0 | Feb 14, 2025 | IFRS |
| Jan - Mar, 2025 | 7 | -259 | -259 | -259 | -4.5 | -3,700.0 | May 14, 2025 | IFRS |
| Apr - Jun, 2025 | 6 | -191 | -191 | -191 | -3.3 | -3,183.3 | Aug 14, 2025 | IFRS |
| YoY | +20.0% | +43.5% | +41.4% | +41.4% | +43.6% |
Related Articles
Direct Marketing MiX, First Half Net Income Increases by 40%, Apr-Jun Net Income Increases by 2.9 times
RaQualia Pharma, First Half Ordinary Profit Loss Widens, Apr-Jun Ordinary Profit Loss Widens
FunPep Company, First Half Net Income Loss Widens, Apr-Jun Net Income Loss Widens
MOBCAST HOLDINGS, First Half Net Income Turns to Loss, Apr-Jun Net Income Loss Widens
AViC, Oct-Jun (Cumulative 3Q) Ordinary Profit Increases by 67%, Apr-Jun Ordinary Profit Increases by 73%
Net Protections, Net Income Forecast for First Half Revised Upward by 23%, Exceeded Record Profit Forecast, Full Year also Increased
BASE, First Half Ordinary Profit Increases by 23%, Apr-Jun Ordinary Profit Increases by 21%
AVIX Inc, Apr-Jun (1Q) Ordinary Profit Loss Narrows
T&S Group, Oct-Jun (Cumulative 3Q) Ordinary Profit 534 Million Yen
Toho Zinc, Apr-Jun (1Q) Ordinary Profit Turns to Loss